Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Essential thrombocythemia: a hypercoagulable state.

R F Hunter Mellado1, J Oppenheimer Catalá, J Vázquez Medina

  • 1Department of Medicine Hospital Universitario Ramon Ruiz Arnau, Universidad Central del Caribe.

Boletin De La Asociacion Medica De Puerto Rico
|October 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A strategic supportive model for health prevention in the elderly: profile of a Puerto Rican geriatric population in a public health sector.

Boletin de la Asociacion Medica de Puerto Rico·1997
See all related articles

Essential thrombocythemia, a condition causing high platelet counts, often presents with hypercoagulable symptoms that improve with treatment. This study found no catastrophic events in 13 patients over 17.5 months.

Area of Science:

  • Hematology
  • Oncology

Background:

  • Essential thrombocythemia is a myeloproliferative neoplasm.
  • Characterized by clonal megakaryocyte proliferation and thrombocytosis.

Purpose of the Study:

  • To analyze the presenting manifestations of Essential Thrombocythemia.
  • To correlate symptoms with thrombocytosis and treatment response.

Main Methods:

  • Retrospective analysis of 13 Essential Thrombocythemia patients.
  • Review of presenting symptoms, clinical findings, and follow-up data.

Main Results:

  • Hypercoagulable state symptoms were frequent at presentation.
  • Symptoms improved significantly upon control of thrombocytosis.
  • Constitutional symptoms, organomegaly, leukocytosis, and eosinophilia were common.

Related Experiment Videos

  • No catastrophic events observed during a mean follow-up of 17.5 months.

    • Conclusions:

    • Symptomatic hypercoagulability is a key presentation of Essential Thrombocythemia.
    • Effective thrombocytosis control leads to symptom resolution.
    • Essential Thrombocythemia may have a favorable prognosis regarding catastrophic events in the short term.